New User? Sign Up | Sign In

Insider Trading - Aquestive Therapeutics Inc. (AQST)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Email a friend >>...

SPAC List: List of Special Purpose Acquisition Companies

AQST Insider Trading Transactions for Aquestive Therapeutics Inc.
Goto page 0, 1, 2, 3, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-03-16
Purchase
2020-03-18
4:45 pm
Aquestive Therapeutics Inc. AQST BRAENDER LORI J
VP
14,000 $1.5446 $21,624 25,000
(Direct)
View
2020-04-29
Sale
2020-05-01
4:05 pm
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
CIO
40,000 $4.5 $180,000 1,022,113
(Direct)
View
2020-04-14
Sale
2020-05-04
4:05 pm
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
CIO
80,000 $3.85 $308,000 942,113
(Direct)
View
2020-05-08
Sale
2020-05-11
4:15 pm
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
CIO
40,000 $5 $200,000 902,113
(Direct)
View
2020-06-04
Sale
2020-06-05
4:05 pm
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
50,000 $5.1062 $255,310 638,964
(Direct)
View
2020-08-18
Sale
2020-08-19
08:55 am
Aquestive Therapeutics Inc. AQST Maxwell John T.
CFO
3,000 $8 $24,000 150,614
(Direct)
View
2021-02-08
Sale
2021-02-09
4:00 pm
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
CIO
40,792 $6.5 $265,148 872,000
(Direct)
View
2021-02-09
Sale
2021-02-10
8:17 pm
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
CIO
35,000 $6.75 $236,250 837,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-03-16
Option Award
2020-03-18
4:45 pm
N/A
2030-03-16
Aquestive Therapeutics Inc. AQST BRAENDER LORI J
VP
60,000 $0 60,000
(Direct)
View
2020-03-16
Option Award
2020-03-18
4:46 pm
N/A
2030-03-16
Aquestive Therapeutics Inc. AQST Barber Daniel
COO
110,000 $0 110,000
(Direct)
View
2020-03-16
Option Award
2020-03-18
4:46 pm
N/A
2030-03-16
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
225,000 $0 225,000
(Direct)
View
2020-03-16
Option Award
2020-03-18
4:46 pm
N/A
2030-03-16
Aquestive Therapeutics Inc. AQST Marshall Ken W.
SVP Chief Commercial Officer
45,400 $0 45,400
(Direct)
View
2020-03-16
Option Award
2020-03-18
4:47 pm
N/A
2030-03-16
Aquestive Therapeutics Inc. AQST Maxwell John T.
CFO
60,000 $0 60,000
(Direct)
View
2020-03-16
Option Award
2020-03-18
4:47 pm
N/A
2030-03-16
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
CIO
70,000 $0 70,000
(Direct)
View
2020-03-16
Option Award
2020-03-18
4:48 pm
N/A
2030-03-16
Aquestive Therapeutics Inc. AQST Wood Theresa
VP
30,000 $0 30,000
(Direct)
View
2020-03-16
Option Award
2020-03-18
4:48 pm
N/A
2030-03-16
Aquestive Therapeutics Inc. AQST Slatko Gary H
SVP Chief Medical Officer
50,000 $0 50,000
(Direct)
View
2020-03-31
Exercise
2020-04-02
4:16 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
CIO
329 $0 1,062,210
(Direct)
View
2020-03-31
Tax Withholding
2020-04-02
4:16 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
CIO
97 $2.19 1,062,113
(Direct)
View
2020-03-31
Exercise
2020-04-02
4:16 pm
2020-03-31
N/A
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
CIO
329 $0 333
(Direct)
View
2020-03-31
Exercise
2020-04-02
4:16 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
329 $0 680,983
(Direct)
View
2020-03-31
Tax Withholding
2020-04-02
4:16 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
99 $2.19 680,884
(Direct)
View
2020-03-31
Exercise
2020-04-02
4:16 pm
2020-03-31
N/A
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
329 $0 333
(Direct)
View
2020-05-31
Exercise
2020-06-02
5:13 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
14,572 $0 695,456
(Direct)
View
2020-05-31
Tax Withholding
2020-06-02
5:13 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
6,492 $4.87 688,964
(Direct)
View
2020-05-31
Exercise
2020-06-02
5:13 pm
2020-05-31
N/A
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
14,572 $0 0
(Direct)
View
2020-05-31
Exercise
2020-06-02
5:14 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
CIO
14,572 $0 916,685
(Direct)
View
2020-05-31
Tax Withholding
2020-06-02
5:14 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
CIO
4,132 $4.87 912,553
(Direct)
View
2020-05-31
Exercise
2020-06-02
5:14 pm
2020-05-31
N/A
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
CIO
14,572 $0 0
(Direct)
View
2020-06-16
Option Award
2020-06-18
4:05 pm
2021-06-16
2030-06-16
Aquestive Therapeutics Inc. AQST Cochran John
Director
14,000 $0 14,000
(Direct)
View
2020-06-16
Option Award
2020-06-18
4:05 pm
2021-06-16
2030-06-16
Aquestive Therapeutics Inc. AQST BRATTON DOUGLAS K
Director
10% Owner
14,000 $0 14,000
(Direct)
View
2020-06-16
Option Award
2020-06-18
4:05 pm
2021-06-16
2030-06-16
Aquestive Therapeutics Inc. AQST COSTA SANTO J
Director
14,000 $0 14,000
(Direct)
View
2020-06-16
Option Award
2020-06-18
4:05 pm
2021-06-16
2030-06-16
Aquestive Therapeutics Inc. AQST Lurker Nancy
Director
14,000 $0 14,000
(Direct)
View
2020-06-16
Option Award
2020-06-18
4:05 pm
2021-06-16
2030-06-16
Aquestive Therapeutics Inc. AQST Scibetta James S
Director
14,000 $0 14,000
(Direct)
View
2020-06-16
Option Award
2020-06-18
5:12 pm
2021-06-16
2030-06-16
Aquestive Therapeutics Inc. AQST BROWN GREGORY B
Director
14,000 $0 14,000
(Direct)
View
2020-06-30
Exercise
2020-07-02
4:00 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
333 $0 639,297
(Direct)
View
2020-06-30
Tax Withholding
2020-07-02
4:00 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
148 $4.86 639,149
(Direct)
View
2020-06-30
Exercise
2020-07-02
4:00 pm
2020-06-30
N/A
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
333 $0 0
(Direct)
View
2020-06-30
Exercise
2020-07-02
4:00 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
CIO
333 $0 912,886
(Direct)
View
2020-06-30
Tax Withholding
2020-07-02
4:00 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
CIO
94 $4.86 912,792
(Direct)
View
2020-06-30
Exercise
2020-07-02
4:00 pm
2020-06-30
N/A
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
CIO
333 $0 0
(Direct)
View
2020-12-30
Gift
2021-01-04
4:05 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
1,000 $0 638,149
(Direct)
View
2020-12-30
Gift
2021-01-04
4:05 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
1,000 $0 1,000
(Indirect)
View
2020-12-30
Gift
2021-01-04
4:05 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
1,000 $0 637,149
(Direct)
View
2020-12-30
Gift
2021-01-04
4:05 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
1,000 $0 1,000
(Indirect)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST Boyd Peter E.
VP
35,000 $0 35,000
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST Barber Daniel
COO
100,000 $0 100,000
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
CIO
70,000 $0 70,000
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST Taglietti Marco
Director
28,500 $0 28,500
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST BRAENDER LORI J
VP
75,000 $0 75,000
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST Marshall Ken W.
SVP Chief Commercial Officer
40,000 $0 40,000
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
250,000 $0 250,000
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST Wood Theresa
VP
27,000 $0 27,000
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST TOTH A ERNEST JR
CFO
2,500 $0 2,500
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST Krop Julie
Director
28,500 $0 28,500
(Direct)
View
2021-03-12
Other
2021-03-16
8:20 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Cochran John
Director
23,038 $0 98,123
(Direct)
View
2021-03-12
Other
2021-03-16
8:20 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Cochran John
Director
8,228 $0 106,351
(Direct)
View
2021-03-12
Other
2021-03-16
8:20 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Cochran John
Director
11,544 $0 117,895
(Direct)
View
2021-03-12
Other
2021-03-16
8:20 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Cochran John
Director
19,091 $0 136,986
(Direct)
View
2021-03-12
Other
2021-03-16
8:20 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST BRATTON DOUGLAS K
MonoLine Partners L.P.
MonoLine RX L.P.
MonoLine RX II L.P.
MonoLine RX III L.P.
MonoSol Rx Genpar L.P.
MRX Partners LLC
Bratton Capital Inc.
Bratton Capital Management L.P.
10% Owner
524,675 $0 1,688,639
(Indirect)
View
2021-03-12
Other
2021-03-16
8:20 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST BRATTON DOUGLAS K
MonoLine Partners L.P.
MonoLine RX L.P.
MonoLine RX II L.P.
MonoLine RX III L.P.
MonoSol Rx Genpar L.P.
MRX Partners LLC
Bratton Capital Inc.
Bratton Capital Management L.P.
10% Owner
564,160 $0 3,468,747
(Indirect)
View
2021-03-12
Other
2021-03-16
8:20 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST BRATTON DOUGLAS K
MonoLine Partners L.P.
MonoLine RX L.P.
MonoLine RX II L.P.
MonoLine RX III L.P.
MonoSol Rx Genpar L.P.
MRX Partners LLC
Bratton Capital Inc.
Bratton Capital Management L.P.
10% Owner
97,598 $0 2,657,943
(Indirect)
View
2021-03-12
Other
2021-03-16
8:20 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST BRATTON DOUGLAS K
MonoLine Partners L.P.
MonoLine RX L.P.
MonoLine RX II L.P.
MonoLine RX III L.P.
MonoSol Rx Genpar L.P.
MRX Partners LLC
Bratton Capital Inc.
Bratton Capital Management L.P.
10% Owner
40,404 $0 47,051
(Indirect)
View
2021-03-12
Other
2021-03-16
8:20 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST BRATTON DOUGLAS K
MonoLine Partners L.P.
MonoLine RX L.P.
MonoLine RX II L.P.
MonoLine RX III L.P.
MonoSol Rx Genpar L.P.
MRX Partners LLC
Bratton Capital Inc.
Bratton Capital Management L.P.
10% Owner
2,249,077 $0 0
(Indirect)
View
2021-03-12
Other
2021-03-16
8:20 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST BRATTON DOUGLAS K
MonoLine Partners L.P.
MonoLine RX L.P.
MonoLine RX II L.P.
MonoLine RX III L.P.
MonoSol Rx Genpar L.P.
MRX Partners LLC
Bratton Capital Inc.
Bratton Capital Management L.P.
10% Owner
1,783,578 $0 1,948,578
(Indirect)
View
2021-03-12
Gift
2021-03-16
8:20 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST BRATTON DOUGLAS K
MonoLine Partners L.P.
MonoLine RX L.P.
MonoLine RX II L.P.
MonoLine RX III L.P.
MonoSol Rx Genpar L.P.
MRX Partners LLC
Bratton Capital Inc.
Bratton Capital Management L.P.
10% Owner
62,500 $0 12,585
(Direct)
View
Goto page 0, 1, 2, 3, Next